Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response

Schizophrenia Research

Volumn 58, Issue 1, 2002, Pages 93-97

  Gutiérrez, Blanca ^a   Arranz, María J ^a   Huezo Diaz, Patricia ^a   Dempster, David ^a   Matthiasson, P ^a   Travis, M ^a   Munro, Janet ^a   Osborne, Sarah ^a   Kerwin, Robert W ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Clozapine response; HTR3A; HTR3B; Schizophrenia

Indexed keywords

CLOZAPINE; RECEPTOR SUBUNIT; SEROTONIN 3 RECEPTOR; SEROTONIN 3A RECEPTOR; SEROTONIN 3B RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 11Q; CONTROLLED STUDY; DRUG EFFECT; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CHI-SQUARE DISTRIBUTION; CLOZAPINE; COMPARATIVE STUDY; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENOTYPE; HUMAN; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); RECEPTORS, SEROTONIN; SCHIZOPHRENIA; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0036843194     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(02)00205-0     Document Type: Article

References (20)

1. Arranz M.J., Munro J., Kirov G., Kerwin R.W., Collier D.A. Novel polymorphisms detected in the 5-HT3 receptor gene: association studies with schizophrenia and clozapine response. Am. J. Med. Genet. 74:1997;615.
2. Arranz M.J., Munro J., Osborne S., Gutiérrez B., Huezo P., Dempster D., Hassan B.A., Niesler B., Rappold G.A., Kerwin R.W. Novel polymorphisms in 5-HT3A receptor gene not related to schizophrenia and clozapine response. Am. J. Med. Genet. 96:2000;538.
3. Bloom F.E., Morales M. The central 5-HT3 receptor in CNS disorders. Neurochem. Res. 23:1998;653-659.
4. Davies P.A., Pistis M., Hanna M.C., Peters J.A., Lambert J.J., Hales T.G., Kirkness E.F. The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature. 397:1999;359-363.
5. Detera-Wadleigh S.D., Berrettini W.H., Yoshikawa T., Badner J.A., Sanders A.R., Goldin L.R. Linkage disequilibrium detects a potential susceptibility locus for bipolar disorder at 11q22-24. Am. J. Med. Genet. 74:1997;669.
6. Endicott J., Spritzer R.L., Fleiss J.L., Cohen J. The global assessment scale. Arch. Gen. Psychiatry. 55:1976;S5-S12.
7. Hermann B., Wetzel C.H.R., Pestel E., Zieglgnsberger W., Holsboer F., Rupprecht R. Functional antagonistic properties of clozapine at the 5-HT3 receptor. Biochem. Biophys. Res. Commun. 225:1996;957-960.
8. Kane J.M. Clinical efficacy of clozapine in treatment - refractory schizophrenia: an overview. Br. J. Psychiatry. 17:1992;41-45.
9. Levinson D.F., Mahtani M.M., Nancarrow D.J., Brown D.M., Kruglyak L., Kirby A. Genome scan of schizophrenia. Am. J. Psychiatry. 155:1998;741-750.
10. Lewontin R.C. The interaction of selection and linkage. General considerations: heterotic models. Genetics. 49:1964;49-67.
11. Lieberman J.A., Safferman A.Z., Pollack S., Szymanski S., Johns C., Howard A., Kronig M., Bookstein P., Kane J.M. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am. J. Psychiatry. 151(12):1994;1744-1752.
12. Maricq A.V., Peterson A.S., Brake A.J., Myers R.M., Julius D. Primary structure and functional expression of the 5-HT3 receptor, a serotonin-gated ion channel. Science. 254:1991;432-437.
13. Maziade M., Raymond V., Cliche D., Fournier J.P., Caron C., Garneau Y. Linkage results on 11q21-22 in eastern Quebec pedigrees densely affected by schizophrenia. Am. J. Med. Genet. 60:1995;522-528.
14. Niesler B., Weiss B., Fischer C., Nöthen M.M., Propping P., Bondy B., Rietschel M., Maier W., Albus M., Franzek E., Rappold G.A. Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients. Pharmacogenetics. 11:2001;21-27.
15. Niesler B., Flohr T., Nöthen M.M., Fischer C., Rietschel M., Franzek E., Albus M., Propping P., Rappold G.A. Association between the 5′UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics. 11:2001;1-5.
16. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and polymorphisms using the polymerase chain reaction. Genomics. 5:1989;874-879.
17. Richelson E., Souder T. Binding of antipsychotic drugs to human brain receptors - focus on newer generation compounds. Life Sci. 68(1):2000;29-39.
18. Schneider S., Kuefer J.M., Roessli D., Excoffier L. Arlequin (version 1.0): A Software Environment for the Analysis of Population Genetics Data. 1996;Genetics and Biometry Lab., University of Geneva, Geneva.
19. Wang R.Y., Ashby C.R., Edwards E., Zhang J.Y. The role of 5-HT3-like receptors in the action of clozapine. J. Clin. Psychiatry. 55:1994;23-26.
20. Weiss B., Mertz A., Schröck E., Koenen M., Rappold G.A. Assignment of a human homolog of the mouse HTR3 receptor gene to chromosome 11q23.1-q23.2. Genomics. 29:1995;304-305.